Literature DB >> 21336818

Acetate-free blood purification can impact improved nutritional status in hemodialysis patients.

Kazuhiro Matsuyama1, Tadashi Tomo, Jun-ichi Kadota.   

Abstract

Effects of online hemodiafiltration (HDF) using acetate-free bicarbonate dialysis (AFD) fluid on microinflammation, resulting in improved nutritional status in hemodialysis patients, were examined and compared with conventional acetate-containing bicarbonate dialysis (ACD) fluid. A total of 24 hemodialysis patients were registered for a cross-over design study for a 6-month period. These patients were subjected to ACD for the first 3 months followed by AFD fluid for the latter 3 months. Blood variables of C-reactive protein (CRP), interleukin-6 (IL-6), leptin, neuropeptide Y (NPY), protein catabolic rate (PCR) and %creatinine (Cr) index were determined after the first and last 3-month period. The filters and the conditions of HDF and drug regimens including erythropoiesis-stimulating agents were unchanged throughout the cross-over study. Predialysis blood pH and bicarbonate were significantly higher in the AFD phase than in the ACD phase. Blood CRP and IL-6 levels were significantly decreased in the AFD group compared to the ACD group. Concerning nutritional evaluation, leptin and NPY were significantly lower and higher, respectively, in the AFD phase than in the ACD phase. PCR tended to be higher in the AFD phase than in the ACD phase. A significantly higher %Cr index level was observed in the AFD phase than in the ACD phase. These results suggest that online HDF using AFD fluid contributes to alleviating bioincompatible events associated with microinflammation, leading to improvement in the nutritional status in hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336818     DOI: 10.1007/s10047-010-0551-7

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  38 in total

1.  A comparison of bicarbonate hemodialysis, hemodiafiltration, and acetate-free biofiltration on cytokine production.

Authors:  Terumi Higuchi; Chii Yamamoto; Tsutomu Kuno; Kazuyoshi Okada; Masayoshi Soma; Noboru Fukuda; Yuji Nagura; Susumu Takahashi; Koichi Matsumoto
Journal:  Ther Apher Dial       Date:  2004-12       Impact factor: 1.762

2.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

3.  CD31 expression on leukocytes is downregulated in vivo during hemodialysis.

Authors:  K Kawabata; S Nakai; M Miwa; T Sugiura; Y Otsuka; T Shinzato; N Hiki; I Tomimatsu; Y Ushida; F Hosono; K Maeda
Journal:  Nephron       Date:  2001-10       Impact factor: 2.847

4.  Interleukin-6 may mediate malnutrition in chronic hemodialysis patients.

Authors:  Y Kaizu; M Kimura; T Yoneyama; K Miyaji; I Hibi; H Kumagai
Journal:  Am J Kidney Dis       Date:  1998-01       Impact factor: 8.860

5.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

6.  Interleukin-6 induces skeletal muscle protein breakdown in rats.

Authors:  M N Goodman
Journal:  Proc Soc Exp Biol Med       Date:  1994-02

7.  Induction of NO synthase 2 in ventricular cardiomyocytes incubated with a conventional bicarbonate dialysis bath.

Authors:  Eleonora Grandi; Marco Govoni; Simone Furini; Stefano Severi; Emanuele Giordano; Antonio Santoro; Silvio Cavalcanti
Journal:  Nephrol Dial Transplant       Date:  2008-02-14       Impact factor: 5.992

8.  Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation.

Authors:  Marta Todeschini; Daniela Macconi; Nuria García Fernández; Marina Ghilardi; Agostina Anabaya; Elena Binda; Marina Morigi; Dario Cattaneo; Elena Perticucci; Giuseppe Remuzzi; Marina Noris
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

9.  C-reactive protein as an outcome predictor for maintenance hemodialysis patients.

Authors:  W F Owen; E G Lowrie
Journal:  Kidney Int       Date:  1998-08       Impact factor: 10.612

10.  Normalized protein catabolic rate versus serum albumin as a nutrition status marker in pediatric patients receiving hemodialysis.

Authors:  Marisa Juarez-Congelosi; Pamela Orellana; Stuart L Goldstein
Journal:  J Ren Nutr       Date:  2007-07       Impact factor: 3.655

View more
  5 in total

Review 1.  Journal of Artificial Organs 2011: the year in review.

Authors:  Y Sawa; E Tatsumi; A Funakubo; T Horiuchi; K Iwasaki; A Kishida; T Masuzawa; K Matsuda; A Myoui; M Nishimura; T Nishimura; S Tokunaga; Y Tomizawa; T Tomo; T Tsukiya; T Yamaoka
Journal:  J Artif Organs       Date:  2012-02-29       Impact factor: 1.731

2.  A case of anaphylactoid reaction to acetate in acetate-containing bicarbonate dialysate.

Authors:  Taro Misaki; Yumiko Suzuki; Yoshitaka Naito; Tempei Shiooka; Taisuke Isozaki
Journal:  CEN Case Rep       Date:  2014-09-04

3.  Citric Acid-Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns Study.

Authors:  Pablo Ureña-Torres; Brian Bieber; Fitsum Guebre-Egziabher; Rim Ossman; Michel Jadoul; Masaaki Inaba; Bruce M Robinson; Friedrich Port; Christian Jacquelinet; Christian Combe
Journal:  Kidney360       Date:  2021-02-04

4.  Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood.

Authors:  Shan Huang; Kerstin Sandholm; Nina Jonsson; Anders Nilsson; Anders Wieslander; Gunilla Grundström; Viktoria Hancock; Kristina N Ekdahl
Journal:  Clin Kidney J       Date:  2014-12-01

5.  Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility.

Authors:  Gunilla Grundström; Anders Christensson; Maria Alquist; Lars-Göran Nilsson; Mårten Segelmark
Journal:  BMC Nephrol       Date:  2013-10-09       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.